Representation of cancer in the medical literature--a bibliometric analysis.
AffiliationDepartment of Surgery, Clinical Science Institute, National University of Ireland Galway, Galway, Ireland. firstname.lastname@example.org
Journal Impact Factor
Periodicals as Topic
MetadataShow full item record
CitationRepresentation of cancer in the medical literature--a bibliometric analysis. 2010, 5 (11):e13902 PLoS ONE
AbstractThere exists a lack of knowledge regarding the quantity and quality of scientific yield in relation to individual cancer types. We aimed to measure the proportion, quality and relevance of oncology-related articles, and to relate this output to their associated disease burden. By incorporating the impact factor(IF) and Eigenfactor™(EF) into our analysis we also assessed the relationship between these indices and the output under study.
All publications in 2007 were retrieved for the 26 most common cancers. The top 20 journals ranked by IF and EF in general medicine and oncology, and the presence of each malignancy within these titles was analysed. Journals publishing most prolifically on each cancer were identified and their impact assessed.
63260 (PubMed) and 126845 (WoS) entries were generated, respectively. 26 neoplasms accounted for 25% of total output from the top medical publications. 5 cancers dominated the first quartile of output in the top oncology journals; breast, prostate, lung, and intestinal cancer, and leukaemia. Journals associated with these cancers were associated with much higher IFs and EFs than those journals associated with the other cancer types under study, although these measures were not equivalent across all sub-specialties. In addition, yield on each cancer was related to its disease burden as measured by its incidence and prevalence.
Oncology enjoys disproportionate representation in the more prestigious medical journals. 5 cancers dominate yield, although this attention is justified given their associated disease burden. The commonly used IF and the recently introduced EF do not correlate in the assessment of the preeminent oncology journals, nor at the level of individual malignancies; there is a need to delineate between proxy measures of quality and the relevance of output when assessing its merit. These results raise significant questions regarding the best method of assessment of research and scientific output in the field of oncology.
- Scientific publications in gastroenterology and hepatology journals from Chinese authors in various parts of North Asia: 10-year survey of literature.
- Authors: Gao R, Liao Z, Li ZS
- Issue date: 2008 Mar
- [The long pilgrimage of Spanish biomedical journals toward excellence. Who helps? Quality, impact and research merit].
- Authors: Alfonso F
- Issue date: 2010 Mar
- [Why are there few publications by the Argentine gastroenterology? Considerations on a bibliometric analysis of Argentine publications on gastroenterology].
- Authors: Barreyro FJ, Krabshuis J, Planzer del Campo M, Bai JC
- Issue date: 2009 Mar
- The actual citation impact of European oncological research.
- Authors: López-Illescas C, de Moya-Anegón F, Moed HF
- Issue date: 2008 Jan
- [A scientometric view of Revista Médica de Chile].
- Authors: Krauskopf M, Krauskopf E
- Issue date: 2008 Aug